drugset / Trial / NCT01391572
A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer
Phase 2
Unknown
300 enrolled
Fudan University
Affiliated Hospital of Jiangsu University · collabAnhui Provincial Hospital · collabFirst Affiliated Hospital of Wenzhou Medical University · collabFujian Cancer Hospital · collabJiangsu Cancer Institute & Hospital · collabRenJi Hospital · collabShanghai Chest Hospital · collabShanghai Pulmonary Hospital, Shanghai, China · collabThe Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China · collabThe First Affiliated Hospital of Anhui Medical University · collabThe First Affiliated Hospital of Soochow University · collabZhejiang Cancer Hospital · collabZhejiang University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized phase II trial to estimate the optimal radiation volume of postsurgical radiation for patients with locoregionally advanced thoracic esophageal squamous cell carcinoma (T3-4, any N, M0).
Timeline
- Start
- 2011-04
- Primary completion
- 2013-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cisplatin | Other / unclassified | — | — |
| Background | fluorouracil | Small molecule | — | — |